Nivolumab in patients with rare head and neck carcinomas: A single center's experience.
Oral Oncol
; 101: 104359, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31300270
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Antineoplastic Agents, Immunological
/
Nivolumab
/
Head and Neck Neoplasms
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Oral Oncol
Journal subject:
NEOPLASIAS
Year:
2020
Document type:
Article
Country of publication:
United kingdom